Evonik reports lower sales and earnings; shareholders place more shares ahead of listing
13:32 PM | March 12, 2013 | Natasha Alperowicz
Evonik Industries today reported a 6% drop in fourth-quarter Ebitda, to €492 million ($641.7 million) on 2% lower sales, of €3.27 billion, citing destocking by customers and the economic slowdown. Net...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.